Nephrocare shares tumble 5% | What’s driving the decline?
AI Summary
The decline in Nephrocare Health Services shares due to a potential block deal by promoters raises concerns about investor confidence in the stock. While the company has shown a steady uptrend since its listing, the current selling pressure could signal a shift in sentiment, especially if the stock falls below the ₹670 support level. Retail investors should closely monitor this situation, as further declines may present buying opportunities, but caution is warranted given the potential for increased volatility.
Nephrocare Health Services shares declined more than 5% on Thursday, 24 September, after reports said that a group of promoter and investor entities may sell shares through a block deal worth up to ₹650 crore.
According to media reports, the transaction has a base size of ₹400 crore, with an additional ₹250 crore upsize option. The shares are reportedly being offered at ₹705 per share, representing a discount of around 5% to the stock’s previous closing price of ₹741.90.
Original Article
Published on Livemint
Frequently Asked Questions
What is this article about?
This is a market news update from Livemint, published on 24 September 2026.
Is this news positive or negative for markets?
TopFund's automated sentiment analysis reads this article as neutral in tone, based on the language used in the report. This is a general signal, not investment advice.
Where can I read the full article?
The full article is available at the original source, Livemint — see the "Read Original Article" link on this page.